Results 91 to 100 of about 15,297 (160)

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer. [PDF]

ESMO Open
Borcoman E, Hervieu A, Cropet C, Coquan E, Guigay J, Rolland F, Bernadach M, Charafe E, Legrand F, Dassé E, Le Tourneau C, Gonçalves A.   +11 more
europepmc   +1 more source

Immune-Enhancing Effects of <i>Polygonatum cyrtonema</i> Polysaccharides in Immunodeficient Zebrafish. [PDF]

Curr Issues Mol Biol
Li D, Wang J, Chen N, Chen N.
europepmc   +1 more source

Case Report: Neuroendocrine-marker-negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall. [PDF]

Front Immunol
He W, Tang Y, Li Y, Zhang J, You X, Wu Q.   +5 more
europepmc   +1 more source

Clinical Utility of Body Weight Monitoring During Cisplatin-based Chemotherapy. [PDF]

In Vivo
Odaira N, Yoshino M, Yamashita K, Tanaka Y, Higuchi C, Gocho A, Ueda M, Kato A, Tagawa C, Sasaki N, Katsuyama R, Aoyagi K, Kanda J.   +12 more
europepmc   +1 more source

Real-world treatment outcomes in South Korean patients with epidermal growth factor receptor-mutant non-small cell lung cancer. [PDF]

Korean J Intern Med
Kim YS, Lee EY, Lee HW, Choi JH, Kim TH, Choi YW, Ahn MS.   +6 more
europepmc   +1 more source

Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens. [PDF]

Cancer Innov
Liu J, Mo H, Li Q, Cazzaniga ME, Ma F.
europepmc   +1 more source

Case Report: A rare case of long-term survival in primary pulmonary adenoid cystic carcinoma with bilateral renal and chest wall metastases. [PDF]

Front Oncol
Huang C, Ye Z, Zhou X, Zhang J.
europepmc   +1 more source

Risk factors for vasculitis and vascular pain associated with cisplatin and vinorelbine in adjuvant chemotherapy. [PDF]

Pain Manag
Ishii S, Ichimura T, Ichikura D, Hida N, Nawata S.   +4 more
europepmc   +1 more source

Correction. [PDF]

Lung Cancer Manag
europepmc   +1 more source

Efficacy and safety of oral vinorelbine with concurrent radiotherapy in unresectable stage III non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a single-arm, phase 2 trial. [PDF]

J Natl Cancer Cent
Lian X, Shayan G, Yang S, Liu W, Zhang T, Lv J, Wang W, Wang J, Wang X, Xiao Z, Zhou Z, Bi N, Deng L.   +12 more
europepmc   +1 more source